X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (1384) 1384
humans (1333) 1333
adult (523) 523
testicular neoplasms - pathology (499) 499
index medicus (449) 449
female (416) 416
oncology (400) 400
testicular neoplasms - immunology (396) 396
middle aged (369) 369
cancer (363) 363
animals (273) 273
tumors (271) 271
testicular cancer (259) 259
pathology (245) 245
adolescent (223) 223
testis (220) 220
aged (205) 205
immunology (197) 197
testicular neoplasms - genetics (192) 192
chemotherapy (177) 177
mice (175) 175
immunohistochemistry (170) 170
testicular neoplasms - drug therapy (162) 162
testicular neoplasms - metabolism (151) 151
testicular neoplasms - diagnosis (145) 145
testicular neoplasms - therapy (144) 144
expression (135) 135
urology & nephrology (132) 132
neoplasms, germ cell and embryonal - pathology (127) 127
seminoma (117) 117
child (116) 116
hematology (114) 114
prognosis (114) 114
testicular neoplasms - surgery (112) 112
antineoplastic combined chemotherapy protocols - therapeutic use (111) 111
germ-cell tumors (105) 105
risk factors (101) 101
research (98) 98
medicine & public health (94) 94
young adult (94) 94
testes (92) 92
neoplasm staging (91) 91
diagnosis (89) 89
child, preschool (87) 87
medicine (87) 87
orchiectomy (86) 86
retrospective studies (84) 84
teratoma - immunology (81) 81
cell biology (80) 80
treatment outcome (80) 80
combined modality therapy (79) 79
research article (78) 78
testis - pathology (78) 78
analysis (77) 77
microbiology (77) 77
seminoma - pathology (76) 76
surgery (76) 76
testicular neoplasms (74) 74
gene expression (73) 73
carcinoma (71) 71
immunoenzyme techniques (70) 70
antigens, neoplasm - immunology (69) 69
diagnosis, differential (68) 68
infant (66) 66
proteins (66) 66
antigens, neoplasm - analysis (65) 65
germ cell tumors (65) 65
testicular neoplasms - complications (65) 65
transplantation (65) 65
pregnancy (64) 64
dysgerminoma - immunology (63) 63
multidisciplinary sciences (62) 62
testicular neoplasms - blood (62) 62
risk (60) 60
follow-up studies (59) 59
cell line, tumor (58) 58
neoplasm metastasis (58) 58
testicular neoplasms - epidemiology (58) 58
care and treatment (57) 57
antibodies, monoclonal - immunology (56) 56
neoplasms, germ cell and embryonal - drug therapy (56) 56
immunotherapy (55) 55
apoptosis (54) 54
cisplatin (54) 54
health aspects (54) 54
neoplasms, germ cell and embryonal - genetics (54) 54
tumor cells, cultured (53) 53
metastasis (52) 52
science (52) 52
urology (51) 51
biomarkers, tumor - analysis (50) 50
differentiation (50) 50
stem cells (49) 49
time factors (49) 49
genetic aspects (48) 48
teratoma - pathology (48) 48
testicular neoplasms - etiology (48) 48
testis - metabolism (48) 48
antibodies, monoclonal (47) 47
antigens (47) 47
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1368) 1368
German (21) 21
Japanese (19) 19
French (17) 17
Russian (11) 11
Hungarian (6) 6
Czech (4) 4
Spanish (4) 4
Danish (3) 3
Italian (3) 3
Polish (3) 3
Chinese (2) 2
Norwegian (2) 2
Dutch (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 3868 - 10
Understanding mechanisms of late/acquired cancer immunotherapy resistance is critical to improve outcomes; cellular immunotherapy trials offer a means to probe... 
SURVIVAL | POLYOMAVIRUS | PEMBROLIZUMAB | ADVANCED MELANOMA | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | TUMOR-REGRESSION | DOWN-REGULATION | MERKEL-CELL-CARCINOMA | EXPRESSION | T-CELLS | Polyomavirus Infections - immunology | Tumor Virus Infections - genetics | Tumor Escape - genetics | Tumor Virus Infections - virology | CD8-Positive T-Lymphocytes - transplantation | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Carcinoma, Merkel Cell - therapy | Male | Testicular Neoplasms - secondary | Neoplasm Recurrence, Local - immunology | Carcinoma, Merkel Cell - immunology | Single-Cell Analysis - methods | Genes, MHC Class I - immunology | Tumor Virus Infections - immunology | Tumor Virus Infections - therapy | Costimulatory and Inhibitory T-Cell Receptors - antagonists & inhibitors | Merkel cell polyomavirus - isolation & purification | Immunotherapy, Adoptive - methods | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Carcinoma, Merkel Cell - genetics | Genes, MHC Class I - genetics | Lymphocytes, Tumor-Infiltrating - transplantation | Transplantation, Autologous - methods | Merkel cell polyomavirus - immunology | Testicular Neoplasms - virology | Sequence Analysis, RNA - methods | Testicular Neoplasms - immunology | Antineoplastic Agents, Immunological - therapeutic use | Polyomavirus Infections - virology | Skin Neoplasms - genetics | Skin Neoplasms - virology | Polyomavirus Infections - genetics | Polyomavirus Infections - therapy | Transcription, Genetic - immunology | Carcinoma, Merkel Cell - virology | Neoplasm Recurrence, Local - genetics | CD8-Positive T-Lymphocytes - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Transcription | CD8 antigen | Clinical trials | Lymphocytes T | Ribonucleic acid--RNA | Immunosuppressive agents | Gene sequencing | Metastases | Interfaces | Inhibitors | Immune checkpoint | Lymphocytes | Immunotherapy | Infiltration | Histocompatibility antigen HLA | Tumors | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0179501
Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully... 
CD2 | THERAPY | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | GENES | IMMUNOMODULATORY ACTION | MECHANISMS | MOLECULES | SGI-110 | Colonic Neoplasms - genetics | DNA Methylation - immunology | DNA, Neoplasm - metabolism | Humans | Antigens, Neoplasm - biosynthesis | Ovarian Neoplasms - pathology | Male | Colonic Neoplasms - metabolism | Testicular Neoplasms - pathology | Ovarian Neoplasms - genetics | Colonic Neoplasms - immunology | Female | Ovarian Neoplasms - metabolism | Caco-2 Cells | Antigens, Neoplasm - genetics | Testicular Neoplasms - genetics | Antigens, Neoplasm - immunology | Testicular Neoplasms - metabolism | Antigen Presentation - genetics | DNA Methylation - genetics | Testicular Neoplasms - immunology | Animals | Colonic Neoplasms - pathology | DNA, Neoplasm - immunology | Mice | DNA, Neoplasm - genetics | Ovarian Neoplasms - immunology | Colon cancer | Tumor antigens | Physiological aspects | Development and progression | Genetic aspects | Research | Methylation | Ovarian cancer | Therapy | Biotechnology | Animal models | Ovarian carcinoma | Medical innovations | CD58 antigen | Antigen processing | Genomes | Tissues | Cancer therapies | Immunotherapy | Surgery | Cell cycle | DNA methylation | Inhibition | Colon | Drug dosages | Deoxyribonucleic acid--DNA | Immune system | Antigen presentation | Antigens | Tumor cells | Melanoma | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Patients | Medicine | Inhibitors | Epigenetics | Solid tumors | Tumors | Cancer | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2014, Volume 134, Issue 2, pp. 467 - 477
Preclinical studies with recombinant murine interleukin 4 (IL4) in models of cancer have shown potent tumor growth inhibition. However, systemic administration... 
interleukin‐12 | immunocytokines | vascular targeting | oncofetal fibronectin | interleukin‐4 | interleukin-4 | interleukin-12 | RECOMBINANT HUMAN INTERLEUKIN-4 | NECROSIS-FACTOR-ALPHA | COMBINATION | RENAL-CELL CARCINOMA | PHASE-II TRIAL | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | FUSION PROTEIN | FIBRONECTIN | NON-HODGKIN-LYMPHOMA | IMMUNOCYTOKINE L19-IL2 | Fibrosarcoma - blood supply | Colonic Neoplasms - prevention & control | Humans | Single-Chain Antibodies - administration & dosage | Fibrosarcoma - immunology | Male | Teratocarcinoma - blood supply | Tissue Distribution | Colonic Neoplasms - immunology | Testicular Neoplasms - prevention & control | Teratocarcinoma - immunology | Female | Lymphoma - pathology | Neovascularization, Pathologic - prevention & control | Disease Models, Animal | Colonic Neoplasms - blood supply | Lymphoma - immunology | Antibodies, Monoclonal - pharmacokinetics | Interleukin-4 - immunology | Testicular Neoplasms - immunology | Animals | Interleukin-12 - administration & dosage | Immunoconjugates | Antibodies, Monoclonal - administration & dosage | Interleukin-4 - administration & dosage | Lymphoma - prevention & control | Testicular Neoplasms - blood supply | Fluorescent Antibody Technique | Interleukin-12 - immunology | Mice | Mice, Inbred BALB C | Teratocarcinoma - prevention & control | Fibrosarcoma - prevention & control | Viral antibodies | Fibronectins | Colon cancer | Interleukins | Antibodies | Models | Lymphomas | T cells | Cancer | Medical research | Drug therapy | Tumors | Alternative splicing | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 11/2017, Volume 66, Issue 11, pp. 1463 - 1471
Cerebellar degeneration-related protein 2 (CDR2) has been presumed to be the main antigen for the onconeural antibody Yo, which is strongly associated with... 
Cerebellar degeneration-related protein 2-like | Yo antibody | Immunology | Paraneoplastic cerebellar degeneration | Medicine & Public Health | Cerebellar degeneration-related protein 2 | Oncology | Cancer Research | Ovarian cancer | CELLS | TISSUE | SERA | IMMUNOLOGY | TUMOR-IMMUNITY | BREAST-CANCER | ONCOLOGY | CLONING | PROSTATIC ADENOCARCINOMA | EXPRESSION | CDR2 | ANTIGEN | Immunohistochemistry | Prostatic Neoplasms - metabolism | Autoantigens - metabolism | Paraneoplastic Cerebellar Degeneration - immunology | Breast Neoplasms - immunology | Autoantibodies - blood | Humans | Middle Aged | Kidney - immunology | Paraneoplastic Cerebellar Degeneration - metabolism | Male | Breast Neoplasms - metabolism | Prostatic Neoplasms - immunology | Kidney - metabolism | Female | Ovarian Neoplasms - metabolism | Nerve Tissue Proteins - immunology | Testicular Neoplasms - metabolism | Ovarian Neoplasms - blood | Blotting, Western | Nerve Tissue Proteins - metabolism | Autoantibodies - immunology | Testicular Neoplasms - immunology | Autoantigens - immunology | Aged | Ovarian Neoplasms - immunology | Viral antibodies | Brain | Medical research | Cancer patients | Resveratrol | Physiological aspects | Medicine, Experimental | Antibodies | Cerebellum | Immunoglobulins | Kidneys | Ovarian carcinoma | Tissues | Patients | Human tissues | Proteins | Degeneration | Prostate | Cancer | Kidney transplantation
Journal Article
Journal Article
Human Pathology, ISSN 0046-8177, 09/2017, Volume 67, pp. 85 - 93
Journal Article
BMC Cancer, ISSN 1471-2407, 11/2018, Volume 18, Issue 1, pp. 1062 - 10
Journal Article
European Journal of Immunology, ISSN 0014-2980, 07/2017, Volume 47, Issue 7, pp. 1232 - 1242
Cancer/testis antigen (CTAg) expression is restricted to spermatogenic cells in an immune‐privileged site within the testis. However, these proteins are... 
T cells | MAGE | Cancer testis antigens | Testicular cancer | Tumor immunology | Tcells | TUMOR-ANTIGENS | IMMUNOLOGY | EXPRESSION PATTERNS | CARCINOMA-IN-SITU | MEMORY | GENE | CANCER/TESTIS ANTIGENS | IMMUNOTHERAPY | DIFFERENTIATION | SEMINOMA | LYMPHOCYTES | Neoplasms, Germ Cell and Embryonal - diet therapy | Humans | Male | Neoplasms, Germ Cell and Embryonal - blood | CD4-Positive T-Lymphocytes - immunology | Young Adult | Antigens, Neoplasm - blood | Adult | Membrane Proteins - blood | Antigens, Neoplasm - genetics | Antigens, Neoplasm - immunology | Lymphocyte Activation | Membrane Proteins - genetics | Peptides - immunology | Membrane Proteins - immunology | Enzyme-Linked Immunospot Assay | Neoplasms, Germ Cell and Embryonal - immunology | Orchiectomy | Peptides - pharmacology | Testicular Neoplasms - diet therapy | Testicular Neoplasms - immunology | Interferon-gamma - immunology | Adolescent | Immunologic Memory | CD8-Positive T-Lymphocytes - immunology | Testicular Neoplasms - blood | Proteins | Antigens | T cells | Analysis | Immunological memory | Orchidectomy | Peptides | CD8 antigen | Lymphocytes T | In vitro testing | T cell receptors | Patients | Immunity | Blood | CD4 antigen | Immunogenicity | Lymphocytes | Peripheral blood | Immune privilege | Aberration | Testes | Enzyme-linked immunosorbent assay | Cancer | Tumors
Journal Article
Journal Article
Cancer Letters, ISSN 0304-3835, 2017, Volume 399, pp. 64 - 73
Journal Article